Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to FAM101A (ENSG00000308501) is a non-coding RNA located antisense to the FAM101A gene (also known as RFLNA or Refilin A), which encodes a protein involved in actin cytoskeleton organization[1][2]. The antisense nature suggests a potential regulatory relationship with FAM101A, though its biological significance, functional roles, disease associations, and relevance to pharmacology have not been characterized in the literature. This transcript is not a receptor, enzyme, or typical therapeutic target, but rather a poorly described and possibly regulatory RNA molecule[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to FAM101A.